Business Description
Amniotics AB
ISIN : SE0015961016
Compare
Compare
Traded in other countries / regions
AMNI.Sweden66J.Germany IPO Date
2021-07-06Description
Amniotics AB is a biopharma company focusing on mesenchymal stem cells from amniotic fluid. It provides a novel platform for the production of medically superior mesenchymal stem cells including ethical and medically sound bio-banking opportunities for the newborn.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.24 | |||||
| Equity-to-Asset | 0.1 | |||||
| Debt-to-Equity | 6.38 | |||||
| Debt-to-EBITDA | -0.74 | |||||
| Piotroski F-Score | N/A/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -63.7 | |||||
| 3-Year EPS without NRI Growth Rate | -65.7 | |||||
| 3-Year Book Growth Rate | -51.5 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 47.38 | |||||
| 9-Day RSI | 51.24 | |||||
| 14-Day RSI | 48.86 | |||||
| 6-1 Month Momentum % | -78.65 | |||||
| 12-1 Month Momentum % | -88.13 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.48 | |||||
| Quick Ratio | 0.45 | |||||
| Cash Ratio | 0.17 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.4 | |||||
| Shareholder Yield % | -188.37 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -385.18 | |||||
| ROA % | -80.59 | |||||
| ROIC % | -64.02 | |||||
| ROC (Joel Greenblatt) % | -334.8 | |||||
| ROCE % | -360.41 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.27 | |||||
| EV-to-EBIT | -0.21 | |||||
| EV-to-EBITDA | -0.22 | |||||
| EV-to-FCF | -0.07 | |||||
| Earnings Yield (Greenblatt) % | -476.19 | |||||
| FCF Yield % | -658.11 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Amniotics AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | |||
| EPS (TTM) (kr) | -0.198 | ||
| Beta | 0 | ||
| Volatility % | 94.42 | ||
| 14-Day RSI | 48.86 | ||
| 14-Day ATR (kr) | 0.000251 | ||
| 20-Day SMA (kr) | 0.003795 | ||
| 12-1 Month Momentum % | -88.13 | ||
| 52-Week Range (kr) | 0.0022 - 0.0456 | ||
| Shares Outstanding (Mil) | 2,733.05 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Amniotics AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Amniotics AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Amniotics AB Frequently Asked Questions
What is Amniotics AB(OSTO:AMNI)'s stock price today?
The current price of OSTO:AMNI is kr0.00. The 52 week high of OSTO:AMNI is kr0.05 and 52 week low is kr0.00.
When is next earnings date of Amniotics AB(OSTO:AMNI)?
The next earnings date of Amniotics AB(OSTO:AMNI) is 2024-05-03 Est..
Does Amniotics AB(OSTO:AMNI) pay dividends? If so, how much?
Amniotics AB(OSTO:AMNI) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers